2020, Number 2
Coats disease
Language: Spanish
References: 13
Page: 1-6
PDF size: 215.55 Kb.
ABSTRACT
Introduction: Coats disease is a rare, idiopathic retinal vasculopathy that can progress to exudative retinal detachment and neovascular glaucoma. Typically occurring in childhood, it is the third most common cause of childhood leukocoria.Case report: Patient masculine of two years of age, coming from rural area. You attended consultation, because he/she suckles her he/she noticed that the boy deviates the right eye toward it was since he was born.
Conclusions: Coats disease simulates other retinal vasculopathies and retinoblastoma. The behavior to be followed will depend on the clinical form of presentation and associated complications.
REFERENCES
lvarez-Rivera LG, Abraham-Marín ML, Flores-Orta HJ, Mayorquín-Ruiz M, Cortés-Luna CF. Coat's disease treated with bevacizumab (Avastin®). Arch Soc Esp Oftalmol [Internet]. 2008 Mayo [citado 01/07/2019]; 83(5): [aprox. 2p.]. Disponible en: Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008000500010
Sein J, Tzu J, Murray T, Berrocal A. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids. Ophthalmic Surg Lasers Imaging Retina [Internet] 2016 [citado el 18/05/2019]; 47(5): [aprox. 6p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27183548
Villegas VM, Gold AS, Berrocal AM, Murray TG. Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin Ophthalmol [Internet] 2014 [citado el 18/05/2019]; 8: [aprox. 3p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037307/
Suesskind D, Altpeter E, Schrader M, Bartz-Schmidt KU, Aisenbrey S. Pars plana vitrectomy for treatment of advanced Coats’ disease-presentation of a modified surgical technique and long-term follow-up. Graefes Arch Clin Exp Ophthalmol [Internet] 2014 [citado el 18/05/2019]; 252(6): [aprox. 6p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24218042
Bhat V, D’Souza P, Shah PK, Narendran V. Risk of tractional retinal detachment following intravitreal bevacizumab along with subretinal fluid drainage and cryotherapy for stage 3B Coats’ disease. Middle East Afr J Ophthalmol [Internet] 2016 [citado el 18/05/2019]; 23(2): [aprox. 3p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27162454
Peng J, Zhang Q, Jin H, Fei P, Zhao P. A modified technique for the transconjunctival and sutureless external drainage of subretinal fluid in bullous exudative retinal detachment using a 24-G i.v. catheter. Ophthalmologica [Internet]. 2017 [citado el 18/05/2019]; 238(4): [aprox. 6p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28866667